A Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor
Clinical trial NCT04042116 · SUSPENDED
Trial details
- NCT number
- NCT04042116
- Sponsor
- Clovis Oncology, Inc.
- Status
- SUSPENDED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-29
- Primary completion
- 2023-07-01
- Enrollment
- 227
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.